News for AKER Stock

Akers Biosciences and MyMD Pharmaceuticals Announce Stockholder Approval of Merger Akers’ Proposed Merger Partner MyMD Pharmaceuticals Announces Plans to Initiate COVID-19 Inflammatory Depression Trial Akers’ Proposed Merger Partner MyMD Pharmaceuticals Announces Formation of Scientific Advisory Board Akers Biosciences Announces Shareholder Meeting to Vote on Business Combination with MyMD Pharmaceuticals MyMD Pharmaceuticals Announces New Data on Its Lead Compound MYMD-1 from a Phenotypic Study Performed by Eurofins Discovery Study Identifies Effects of Temperature Changes on SARS-CoV-2 Transmission Akers Biosciences Responds to Erroneous Earnings Call Press Release REMINDER: Akers Biosciences Schedules Conference Call to Discuss Merger with MyMD Pharmaceuticals Akers Biosciences and MyMD Pharmaceuticals Sign Definitive Merger Agreement Akers Biosciences and Premas Biotech Announce SARS CoV-2 Positive Proof of Concept Results Akers Biosciences Announces $4.8 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules Akers Biosciences Closes $4.8 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules Akers Biosciences and Premas Biotech Announce Successful Completion of Vaccine Prototype & Obtained First Images of VLP